Response to Single Low-dose (177)Lu-DOTA-EB-TATE Treatment in Patients with Advanced Neuroendocrine Neoplasm: A Prospective Pilot Study

Objective: (177)Lu-DOTA-EB-TATE is a theranostic agent based on octreotate that uses an Evans blue structure to bind albumin to improve the pharmacokinetics and pharmacodynamics. This pilot study aims to evaluate the efficacy of a single low-dose treatment using (177)Lu-DOTA-EB-TATE in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao, Cheng, Yuejuan, Zhang, Jingjing, Zang, Jie, Li, Hui, Liu, Qingxing, Wang, Jingnan, Jacobson, Orit, Li, Fang, Zhu, Zhaohui, Chen, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010978/
https://www.ncbi.nlm.nih.gov/pubmed/29930731
http://dx.doi.org/10.7150/thno.25919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010978/
https://www.ncbi.nlm.nih.gov/pubmed/29930731
http://dx.doi.org/10.7150/thno.25919

Ejemplares similares